NeuroPace Inc (NPCE) stock

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3013% above fair value

$7.56−4.46 (-37.10%)

Close on Nov 13, 2026Market cap $259.49MP/E –Yield 0.00%

NeuroPace cash

Cash and short-term investments held at the end of each period.

NeuroPace's cash was $49.20M at Sep 30, 2026. For fiscal 2025 it was $61.10M, up 15.7% from the year before. The highest annual figure on record is $115.60M in fiscal 2021.

Annual cash

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$61.10M	+15.7%
FY2024	Dec 31, 2024	$52.80M	-20.6%
FY2023	Dec 31, 2023	$66.50M	-14.1%
FY2022	Dec 31, 2022	$77.40M	-33.0%
FY2021	Dec 31, 2021	$115.60M	+200.7%
FY2020	Dec 31, 2020	$38.45M	+832.5%
FY2019	Dec 31, 2019	$4.12M	–

Quarterly cash

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$49.20M	-18.0%
Q2 FY2026	Jun 30, 2026	$51.70M	-16.7%
Q1 FY2026	Mar 31, 2026	$54.00M	-18.6%
Q4 FY2025	Dec 31, 2025	$61.10M	+15.7%
Q3 FY2025	Sep 30, 2025	$60.00M	+5.6%
Q2 FY2025	Jun 30, 2025	$62.10M	+11.9%
Q1 FY2025	Mar 31, 2025	$66.30M	+12.6%
Q4 FY2024	Dec 31, 2024	$52.80M	-20.6%
Q3 FY2024	Sep 30, 2024	$56.80M	-7.3%
Q2 FY2024	Jun 30, 2024	$55.50M	-12.7%
Q1 FY2024	Mar 31, 2024	$58.90M	-12.9%
Q4 FY2023	Dec 31, 2023	$66.50M	-14.1%
Q3 FY2023	Sep 30, 2023	$61.30M	-28.2%
Q2 FY2023	Jun 30, 2023	$63.60M	-31.2%
Q1 FY2023	Mar 31, 2023	$67.60M	-34.5%
Q4 FY2022	Dec 31, 2022	$77.40M	-33.0%
Q3 FY2022	Sep 30, 2022	$85.40M	-30.7%
Q2 FY2022	Jun 30, 2022	$92.40M	-27.8%
Q1 FY2022	Mar 31, 2022	$103.20M	+238.4%
Q4 FY2021	Dec 31, 2021	$115.60M	+200.7%
Q3 FY2021	Sep 30, 2021	$123.30M	+185.8%
Q2 FY2021	Jun 30, 2021	$127.90M	+1179.1%
Q1 FY2021	Mar 31, 2021	$30.50M	+216.9%
Q4 FY2020	Dec 31, 2020	$38.45M	+832.5%
Q3 FY2020	Sep 30, 2020	$43.14M	–
Q2 FY2020	Jun 30, 2020	$10.00M	–
Q1 FY2020	Mar 31, 2020	$9.62M	–
Q4 FY2019	Dec 31, 2019	$4.12M	–